AVITA Medical to Conduct Investor Webinar Session

Written by Emily J. Thompson, Senior Investment Analyst

Source: Globenewswire

Updated: Nov 09 2025

0mins

Source: Globenewswire

Investor Webinar Announcement: AVITA Medical, Inc. will host an investor webinar on November 12, 2025, featuring Interim CEO Cary Vance and CFO David O’Toole, discussing third-quarter 2025 financial results and a Q&A session.
RECELL System Overview: The company’s RECELL System, FDA-approved for treating thermal burn and trauma wounds, utilizes a patient’s own skin to create Spray-On Skin™ Cells, enhancing wound healing and recovery times.
Product Distribution Rights: AVITA Medical holds exclusive rights in the U.S. to manufacture and distribute PermeaDerm®, a biosynthetic wound matrix, and Cohealyx™, a collagen-based dermal matrix.
International Approvals: The RECELL System is also approved for various skin healing applications in international markets, including Europe, Australia, and Japan, excluding RECELL GO.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

GET FREE REAL TIME NOTIFICATIONS

Stock Monitor for NVDA?

Get Started Free

FREE STOCK RECOMMENDATIONS DAILY

Stock Bullish Tomorrow

Get Started Free

70% BACKTESTED ACCURACY!

Should I Buy NVDA?

Get Started Free